Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Some Effects of Calcium on the Activation of Human Factor VIII/Von Willebrand Factor Protein by Thrombin
Mary Ellen Switzer, Patrick A. McKee
Mary Ellen Switzer, Patrick A. McKee
Published October 1, 1977
Citation Information: J Clin Invest. 1977;60(4):819-828. https://doi.org/10.1172/JCI108836.
View: Text | PDF
Research Article

Some Effects of Calcium on the Activation of Human Factor VIII/Von Willebrand Factor Protein by Thrombin

  • Text
  • PDF
Abstract

When Factor VIII/von Willebrand factor (FVIII/vWF) protein is rechromatographed on 4% agarose in 0.25 M CaCl2, the protein and vWF activity appear in the void volume, but most of the FVIII procoagulant activity elutes later. Recent evidence suggests that the delayed FVIII procoagulant activity is a proteolytically modified form of FVIII/vWF protein that filters anomalously from agarose in 0.25 M CaCl2. To test whether or not thrombin is the protease involved, the effect of 0.25 M CaCl2 on FVIII/vWF and its reaction with thrombin was examined. About 30% of the FVIII procoagulant activity was lost immediately when solutions of FVIII/vWF protein were made 0.25 M in CaCl2. When FVIII in 0.15 M NaCl was activated with 0.04 U thrombin/ml and then made 0.25 M in CaCl2, the procoagulant activity of a broad range of FVIII/vWF protein concentrations remained activated for at least 6 h. But, in 0.25 M CaCl2, the increase in FVIII procoagulant activity in response to thrombin was much more gradual and once activated, the procoagulant activity was stabilized by 0.25 M CaCl2. When thrombin-activated FVIII/vWF protein was filtered on 4% agarose in 0.15 M NaCl, there was considerable inactivation of FVIII procoagulant activity; however, the procoagulant activity that did remain eluted in the void volume. In contrast, when thrombin-activated FVIII/vWF protein was filtered in 0.25 M CaCl2, the FVIII procoagulant activity eluted well after the void volume and remained activated for 6 h. The procoagulant peak isolated by filtering nonthrombin-activated FVIII/vWF protein on agarose in 0.25 M CaCl2 was compared to that isolated from thrombin-activated FVIII/vWF protein. Both procoagulant activity peak proteins had about the same specific vWF activity as the corresponding void volume protein. Before reduction, the sodium dodecyl sulfate gel patterns for the two procoagulant activity peak proteins were the same. After reduction, the gel pattern for the nonthrombin-activated procoagulant activity peak protein contained bands of 195,000, 148,000-120,000, 79,000, 61,000, 51,000, and 18,000 daltons whereas the pattern for the reduced thrombin-activated procoagulant activity peak protein always lacked the higher molecular weight bands, but consistently showed the four lower molecular weight bands to be well resolved. Taken together, these results imply that thrombin generates the FVIII procoagulant activity that is stabilized by 0.25 M CaCl2 and elutes aberrantly from 4% agarose in that solvent.

Authors

Mary Ellen Switzer, Patrick A. McKee

×

Total citations by year

Year: 2023 1993 1990 1989 1987 1986 1984 1983 1982 1981 1980 1978 Total
Citations: 1 1 1 1 1 3 3 2 1 4 3 1 22
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (22)

Title and authors Publication Year
Calcium Prevents Enhanced Degradation of Factor VIII in the Condition of Motion.
Cohen H, Keren-Politansky A, Crispel Y, Yanovich C, Asayag K, Nadir Y
Biology 2023
Application of a new statistical approach to optimize the immunopurification of antihemophilia A factor
N Bihoreau, S Layet, MP Fontaine-Aupart, P Paolantonacci
Journal of Chromatography B: Biomedical Sciences and Applications 1993
Advances in Human Genetics
H Harris, K Hirschhorn
1990
Factor VIII influences binding of factor IX and factor X to intact human platelets
W Muntean, B Leschnik
Thrombosis Research 1989
Factor VIII binds to von Willebrand factor via its Mr-80000 light chain
RJ HAMER, JA KOEDAM, NH BEESER-VISSER, JJ SIXMA, RM BERTINA, JA MOURIK
European Journal of Biochemistry 1987
The physiology and pathophysiology of the factor VIII complex
RJ Hamer, WP Houdijk, JJ Sixma, TW Barrowcliffe
Critical Reviews in Oncology/Hematology 1986
Binding of human thrombin to human factor VIII:RAg
L Hau, BG Firkin, MA Howard
British Journal of Haematology 1986
2. Rundtischgespräch Therapiebedingte Infektionen und Immundefekte bei Hämophilen
G Landbeck, R Marx
1986
Dissociation of the factor-VIII complex during clotting: role of thrombin and phospholipids
W Muntean, HJ Rothwangl
European Journal of Clinical Investigation 1984
The effect of carbohydrate depletion on procoagulant activity and in vivo survival of highly purified human factor VIII
PJ Fay, SI Chavin, JE Malone, D Schroeder, FE Young, VJ Marder
Biochimica et Biophysica Acta (BBA) - General Subjects 1984
Thrombosis and Cardiovascular Disease
A Strano
1984
Binding of native and thrombin activated factor VIII to platelets
K Sewerin, LO Andersson
Thrombosis Research 1983
New Comprehensive Biochemistry
S Yamamoto
New Comprehensive Biochemistry 1983
Influence of high molecular weight factor VIII on the measurement of low molecular weight factor VIII procoagulant in different assay systems
W Muntean, WE Hathaway, RR Montgomery
British Journal of Haematology 1982
OBSERVATIONS ON STRUCTURE-FUNCTION RELATIONSHIPS OF HUMAN ANTIHEMOPHILIC/VON WILLEBRAND FACTOR PROTEIN
PA McKee
Annals of the New York Academy of Sciences 1981
Interaction of factor VIII-von Willebrand Factor with phospholipid vesicles
LO Andersson, JE Brown
Biochemical Journal 1981
Parallel destruction of factor VIII procoagulant activity and an 85,000 dalton protein in highly purified factor VIII/VWF
CG Cockburn, RJ de Beaufre-Apps, J Wilson, RM Hardisty
Thrombosis Research 1981
Partial purification of biologically active, low molecular weight, human antihemophilic factor free of Von Willebrand factor I. Partial characterization and evidence for disulfide bond(s) susceptible to limited reduction
RB Harris, J Newman, AJ Johnson
Biochimica et Biophysica Acta (BBA) - Protein Structure 1981
Ristocetin-induced aggregation of canine platelets
LA Leis, TK Rosborough, GS Johnson, GJ Johnson
Thrombosis Research 1980
Preparation and properties of bovine factor VIII (antihemophilic factor)
GA Vehar, EW Davie
Biochemistry 1980
Reactions of thrombin with human factor VIII/von Willebrande factor protein
ME Switzer, PA McKee
The Journal of biological chemistry 1980
Carbohydrate on human factor VIII/von Willebrand factor. Impairment of function by removal of specific galactose residues
JM Sodetz, JC Paulson, SV Pizzo, PA McKee
The Journal of biological chemistry 1978

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts